2019 Annual Meeting
Chicago, IL, USA
October 17-18

Mapping Neuroethics: An Expanded Vision

The 2019 Annual Meeting of the International Neuroethics Society (INS) will gather a diverse group of scholars, scientists, clinicians, and professionals dedicated to the responsible use of advances in brain science. Attendees will participate in intellectually stimulating and dynamic sessions that will explore neuroethics in a global context.

The INS meeting provides several opportunities for attendees to share their neuroethics research with international colleagues. To be considered for a presentation invitation or travel stipend, you must submit an abstract by June 24. Review the call for abstracts for complete details.

Subscribe to receive email announcements about the INS annual meeting.

 

Plenary Speaker

 

FRED KAVLI DISTINGUISHED NEUROETHICS LECTURE

Martha J. Farah

Center for Neuroscience & Society
University of Pennsylvania

 

  • Talk title: 'Socioeconomic Status and Brain Development: From Science to Policy'

 

Sessions / Discussions

 

Solving Dilemmas in Global Neuroethics

Presentations and a follow-up world cafe discussion with the full audience will examine several themes addressed in the perspective article, 'Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives' (Neuron, 2018). The goal of this session is to promote a productive dialogue on diverse ethical approaches to contemporary issues in global neuroethics.

 

Ethics and the Imprisoned Brain

As researchers begin to investigate techniques for altering inmates' brains to rid prisons of what Anthony Burgess called ‘the ultra-violence,’ the ongoing neuroethics discourse about biological approaches to criminal justice takes on renewed urgency. Speakers will address the promise and peril of neuro-interventions for incarcerated persons, whether in research and development or implementation and oversight.

 

Incapable Patients and the Law of Neurosurgery for Psychiatric Disorders

Many laws define psychosurgery to include deep brain stimulation (DBS) for psychiatric indications, a field under intensive exploration and expansion. This session will consider the history, present and future, of the regulation of invasive psychiatric neuromodulation such as DBS, with particular attention to the questions of whether there is a need for specific law, and what its optimal contents should be.

 

Preclinical Interventions in Psychiatric and Neurological Disorders

As we get better at using genetic, metabolic or behavioral biomarkers to predict future susceptibility for neurological and psychiatric syndromes, the problem of medical management of people in such preclinical states becomes more trenchant. Testing preventive drugs, informing patients or parents of risks, managing false positives, and treating patients with little discernible illness raise significant ethical questions that we will discuss with a panel of experts.

 

Disorders of Consciousness: Concepts, Culture and Prognosis

This session will explore the importance of concepts when addressing disorders of consciousness. Speakers will discuss the cultural dimensions and ethical implications of selecting concepts, how concepts can impact practice protocol and medical decision-making, and the potential consequences of categorizing patients.

 

The full meeting program will be released in the coming weeks. Registration will open in June.  Subscribe to receive email announcements about the program and speakers.

 

 

photo array